TCTR20230712002已完成不适用
Allergic Rhinitis and Other Comorbidities Associated with Asthma Control in Thailand
Thai Asthma Council and Association (TAC), Thailand0 个研究点目标入组 385 人开始时间: 2023年7月12日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 385
研究概览
简要总结
ot-well-controlled asthma was 44.7%. AR was 86.1%. Moderate to severe persistent AR was 21.7% and severe AR was 30.2%. Correlation was found between AR severity and ACT, AQLQ, and total IgE. ACT, AQLQ, and percentage of FEV1/FVC were significantly associated with severe AR.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •1. Asthmatic patients aged 18 years or older, 2. Asthma diagnosed according to the Global Initiative for Asthma strategy
排除标准
- 未提供
研究者
相似试验
尚未招募
不适用
Microbial Study of Sublingual Immunotherapy Tablets in Patients With Allergic RhinitisRhinitis, AllergicNCT06741800The First Affiliated Hospital with Nanjing Medical University100
尚未招募
不适用
Microbial Study of Sublingual Immunotherapy Spray in Patients With Allergic RhinitisRhinitis, AllergicNCT06741787The First Affiliated Hospital with Nanjing Medical University100
进行中（未招募）
2 期
A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis(SAR).Allergic RhinitisNCT06315426Genrix (Shanghai) Biopharmaceutical Co., Ltd.240
已完成
3 期
Study In Adolescent And Adult Subjects 12 Years Of Age And Older With Seasonal Allergic Rhinitis To Assess Onset of ActionRhinitis, Allergic, SeasonalNCT00118729GlaxoSmithKline380
已完成
2 期
Efficacy and Safety of LP-003 in Moderate-to-severe Seasonal Allergic Rhinitis AdultSeasonal Allergic RhinitisNCT06046391Longbio Pharma180